Fundrasing

NeoMed Innovation IV closed at EUR 104 million

NeoMed Innovation IV LP closed at EUR 104 million. The investors are fund-of-funds, institutional and private investors situated in Europe and Saudi Arabia.

NeoMed is one of Europe’s leading venture capital firms which specialises in healthcare and life sciences. It invests in innovative and emerging companies, primarily in Continental Europe and Scandinavia.

The new fund recently made its first investment in the Swiss company Endosense SA.

Read more


Date of Transaction2005-12-30
Closing Final
FundNeoMed Innovation IV LP
ManagerNeomed Management
StageVenture
LocationNorway, USA, RoW
Ind. FocusLife Science
Fund SizeEUR 103.6m
Vintage Year2005
 

More news NeoMed Innovation IV LP

More fundraisings

 
 
Location
Stage
Industry
 
 

Ownership

 
18.34%
NeoMed Innovation IV LP
 
 
 

Latest PE Voice

Harald Mix on Nordic private equity

- 1/10/2012 10:10:00 AM
At the Argentum Conference in 2010, we asked Harald Mix, Managing Partner and Co-founder of Altor Equity Partners about the outlook for future returns in Nordic private equity.
 
 

Calendar

2012-02-16 in Bergen

Vestlandskonferansen

2012-02-27 in Berlin

SuperReturn International 2012

2012-03-05 in Copenhagen

Nordic Fundraising Summit

2012-03-14 in Geneva

EVCA Investors' Forum

2012-03-15 in La Clusaz

EVCA Networking Event 2012
 
Copyright Argentum 2009